Korean Market
PERI
HLB innoVation
★

HLB Innovation: 2025 Consolidated Operating Loss Widens to KRW 37.6B, Separate Entity Turns Profitable; Issued KRW 33B CB for Bio R&D Funding

 
EXCH
HLB innoVation
★

HLB innoVation to Hold NDR for Institutional Investors from June 1-5, Discuss Subsidiary Verismo

 
EXCH
HLB innoVation
★

NDR for Institutional Investors on May 22, 2026: Presentation on Verismo Therapeutics

 
PERI
HLB innoVation
★

HLB Innovation Posts Operating Loss of 10.4B Won in Q1, Semiconductor Unit Profitable

 
EXCH
HLB innoVation
★

Completion of 40.5 Billion KRW Private Convertible Bond Issuance (4th Series, Unlisted)

 
OWNR
HLB innoVation
★

Report on Specific Securities Ownership by Executives/Major Shareholders (No Changes)

 
OWNR
HLB innoVation
★

HLB Group Files Shareholding Report for Management Influence, Enters Call Option Contracts on Convertible Bonds

 
OWNR
HLB innoVation
★

Report on Ownership of Specific Securities by Executives/Major Shareholders (No Changes)

 
OWNR
HLB innoVation
★

Insider/Major Shareholder Securities Ownership Report Filed (No Specifics)

 
OWNR
HLB innoVation
★

Insider/Major Shareholder Securities Ownership Report (No Changes)

 
OWNR
HLB innoVation
★

Submission of Report on Ownership of Specific Securities by Executives and Major Shareholders (No Content)

 
OWNR
HLB innoVation
★

HLB Affiliates File Large Shareholding Report

 
OWNR
HLB innoVation
★

HLB: No Change in Executives' and Major Shareholders' Holdings

 
MATR
HLB innoVation
★

HLB Innovation Decides to Issue Convertible Bonds (with Put and Call Options)

 
EXCH
HLB innoVation
★

HLB Innovation Lifting of Trading Suspension (Stock Split & Change of Listing)